We subsequently produced a more precise probe, [18F]CFA, which was used in The existing analyze To judge dCK activity in tumors when handled with a small molecule dCK inhibitor. This probe can be staying examined inside a clinical trial at our establishment To guage alterations in dCK exercise next most cancers immunotherapy eighteen. PET probes in